These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8383403)

  • 21. Priming and the onset of neuromuscular blockade with alcuronium.
    Black AM; Hutton P; el-Hassan KM; Morgan G; Clutton-Brock TH
    Br J Anaesth; 1986 Aug; 58(8):827-33. PubMed ID: 3730230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of neuromuscular block in the diaphragm and hand after administration of tubocurarine, pancuronium and alcuronium.
    Derrington MC; Hindocha N
    Br J Anaesth; 1990 Mar; 64(3):294-9. PubMed ID: 2328177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative neuromuscular block following atracurium or alcuronium in children.
    Meretoja OA; Gebert R
    Can J Anaesth; 1990 Oct; 37(7):743-6. PubMed ID: 2171792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH; deBros FM
    Anesth Analg; 1981 Jan; 60(1):12-7. PubMed ID: 7192943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evoked electromyographic and mechanical responses of the adductor pollicis compared during the onset of neuromuscular blockade by atracurium or alcuronium, and during antagonism by neostigmine.
    Harper NJ; Bradshaw EG; Healy TE
    Br J Anaesth; 1986 Nov; 58(11):1278-84. PubMed ID: 3778792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The autonomic margins of safety of metocurine and d-tubocurarine in the cat.
    Savarese JJ
    Anesthesiology; 1979 Jan; 50(1):40-6. PubMed ID: 83803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced neuromuscular transmission safety factor in multiple sclerosis.
    Eisen A; Yufe R; Trop D; Campbell I
    Neurology; 1978 Jun; 28(6):598-602. PubMed ID: 206859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed onset of alcuronium effect in children with cyanotic congenital heart disease.
    Keneally JP; Goonetilleke PH; Ramzan IM
    Anaesth Intensive Care; 1993 Apr; 21(2):197-200. PubMed ID: 8517511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five non-depolarizing muscle relaxants in precurarization.
    Erkola O; Salmenperä A; Kuoppamäki R
    Acta Anaesthesiol Scand; 1983 Dec; 27(6):427-32. PubMed ID: 6141695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
    Kopman AF
    Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neuromuscular transmission monitor. A clinical assessment and comparison with a force transducer.
    Windsor JP; Sebel PS; Flynn PJ
    Anaesthesia; 1985 Feb; 40(2):146-51. PubMed ID: 2983581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response curves for four neuromuscular blockers using continuous i.v. infusion.
    Shanks CA; Walker JS; Ramzan MI; Triggs EJ
    Br J Anaesth; 1981 Jun; 53(6):627-33. PubMed ID: 7248126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-response curves for alcuronium and pancuronium alone and in combination.
    Shanks CA
    Anaesth Intensive Care; 1982 Aug; 10(3):248-51. PubMed ID: 7125191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of respiration after neuromuscular blockade with alcuronium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1987 Feb; 59(2):206-10. PubMed ID: 3030384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of the neuromuscular blockade produced by alcuronium with halothane, enflurane and isoflurane.
    Keens SJ; Hunter JM; Snowdon SL; Utting JE
    Br J Anaesth; 1987 Aug; 59(8):1011-6. PubMed ID: 3651269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does suxamethonium influence the subsequent dose requirements of alcuronium and its reversibility in children?
    Brown TC; Meretoja OA; Clare D; Bell B
    Anaesth Intensive Care; 1990 Nov; 18(4):479-82. PubMed ID: 2268013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Anesth Analg; 1990 Jul; 71(1):55-9. PubMed ID: 2363529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of competitive antagonists: the anti-curare action of hexamethonium and other antagonists at the skeletal neuromuscular junction.
    Blackman JG; Gauldie RW; Milne RJ
    Br J Pharmacol; 1975 May; 54(1):91-100. PubMed ID: 166720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromuscular blocking properties of dioxonium.
    Tammisto T; Salmenperä M
    Acta Anaesthesiol Scand; 1980 Dec; 24(6):439-43. PubMed ID: 7246027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the action kinetics of alcuronium and vecuronium by electromyographic monitoring].
    Lapeyre G; Chevreaud C; Manel J; Mialhe C; Laxenaire MC
    Ann Fr Anesth Reanim; 1988; 7(1):3-7. PubMed ID: 2894789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.